Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis

Clinical Microbiology and Infection

Volumn 19, Issue 11, 2013, Pages

  Psoter, K J ^a   De Roos, A J ^b   Wakefield, J ^a   Mayer, J ^a   Rosenfeld, M ^c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DREXEL UNIVERSITY   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acquisition; Climate; Cystic fibrosis; Pseudomonas aeruginosa; Seasonality

Indexed keywords

ARTICLE; AUTUMN; CHILD; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SEASONAL VARIATION; SPRING; STAPHYLOCOCCUS INFECTION; SUMMER; UNITED STATES; WINTER;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ACQUISITION; CLIMATE; CYSTIC FIBROSIS; PSEUDOMONAS AERUGINOSA; SEASONALITY;

CHILD; CHILD, PRESCHOOL; CLIMATE; CYSTIC FIBROSIS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SEASONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 84885471838     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12272     Document Type: Article

References (30)

1. Fisman DN. Seasonality of infectious diseases. Annu Rev Public Health 2007; 28: 127-143.
2. Grassly NC, Fraser C. Seasonal infectious disease epidemiology. Proc Biol Sci 2006; 273: 2541-2550.
3. Cystic Fibrosis Foundation. National Patient Registry 2011 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 2012.
4. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995; 48: 1041-1049.
5. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100.
6. Nixon GM, Armstrong DS, Carzino R et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138: 699-704.
7. Burns JL, Gibson RL, McNamara S et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001; 183: 444-452.
8. Speert DP, Campbell ME, Henry DA et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 2002; 166: 988-993.
9. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997; 23: 330-335.
10. Griese M, Muller I, Reinhardt D. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Eur J Med Res 2002; 7: 79-80.
11. Rosenfeld M, Gibson RL, McNamara S et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001; 32: 356-366.
12. Spencer DH, Kas A, Smith EE et al. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 2003; 185: 1316-1325.
13. Farrell PM, Shen G, Splaingard M et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997; 100: E2.
14. Johansen HK, Høiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992; 47: 109-111.
15. Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155 (6 Suppl): S73-S93.
16. Peel MC, Finlayson BL, McMahon TA. Updated world map of the Koppen-Geiger climate classification. Hydrol Earth Syst Sci 2007; 11: 1633-1644.
17. Perencevich EN, McGregor JC, Shardell M et al. Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol 2008; 29: 1124-1131.
18. Agius AM, Pickles JM, Burch KL. A prospective study of otitis externa. Clin Otolaryngol Allied Sci 1992; 17: 150-154.
19. Hawke M, Wong J, Krajden S. Clinical and microbiological features of otitis externa. J Otolaryngol 1984; 13: 289-295.
20. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002; 112(7 Pt 1): 1166-1177.
21. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea 2008; 27: 33-39.
22. Collaco JM, McGready J, Green DM et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS ONE 2011; 6: e27784.
23. Harrison LM, Morris JA, Bishop LA, Lauder RM, Taylor CAM, Telford DR. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS). FEMS Immunol Med Microbiol 2004; 42: 94-104.
24. Stapleton F, Keay LJ, Sanfilippo PG, Katiyar S, Edwards KP, Naduvilath T. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. Am J Ophthalmol 2007; 144: 690-698.
25. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 816-821.
26. Asner S, Waters V, Solomon M et al. Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros 2012; 11: 433-439.
27. McIsaac SM, Stadnyk AW, Lin TJ. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. J Leukoc Biol 2012; 92: 977-985.
28. Rosenfeld M, Emerson J, McNamara S et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 2012; 11: 446-453.
29. Schelstraete P, Van Daele S, De Boeck K et al. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Eur Respir J 2008; 31: 822-829.
30. Rosenfeld M, Emerson J, Accurso F et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321-328.